These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 720388)

  • 1. Protection against alloxan-induced diabetes in mice by the hydroxyl radical scavenger dimethylurea.
    Heikkila RE; Cabbat ES
    Eur J Pharmacol; 1978 Nov; 52(1):57-60. PubMed ID: 720388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against alloxan-induced diabetes by various urea derivatives: relationship between protective effects and reactivity with the hydroxyl radical.
    Tibaldi J; Benjamin J; Cabbat FS; Heikkila RE
    J Pharmacol Exp Ther; 1979 Nov; 211(2):415-8. PubMed ID: 501570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevention of alloxan-induced diabetes in mice by dimethyl sulfoxide.
    Heikkila RE
    Eur J Pharmacol; 1977 Jul; 44(2):191-3. PubMed ID: 885168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of blood glucose in the dimethylthiourea-induced protection against alloxan-induced diabetes.
    Masukawa T; Nakanishi K
    Jpn J Pharmacol; 1994 Sep; 66(1):159-61. PubMed ID: 7861663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against alloxan-induced diabetes by diethyldithiocarbamate and disulfiram in mice.
    Masukawa T; Nakanishi K
    Jpn J Pharmacol; 1994 Mar; 64(3):141-6. PubMed ID: 8022115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in the diabetogenic effect of alloxan in mice by treatment with the antineoplastic agent ICRF-187.
    El-Hage AN; Herman EH; Ferrans VJ
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):509-23. PubMed ID: 7036302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against alloxan-induced diabetes in mice by the free radical scavenger butylated hydroxyanisole.
    Cowden WB; Lewis-Hughes PH; Clark IA
    Biochem Pharmacol; 1985 Oct; 34(19):3601-3. PubMed ID: 2996554
    [No Abstract]   [Full Text] [Related]  

  • 8. The prevention of alloxan-induced diabetes by the immunosuppressive agent azathioprine.
    Heikkila RE; Cabbat FS
    Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):163-71. PubMed ID: 7196067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloxan-induced diabetes-evidence for hydroxyl radical as a cytotoxic intermediate.
    Heikkila RE; Winston B; Cohen G
    Biochem Pharmacol; 1976 May; 25(9):1085-92. PubMed ID: 773385
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of protection from alloxan diabetes provided by n-butanol.
    Schauberger CW; Thies RL; Fischer LJ
    J Pharmacol Exp Ther; 1977 May; 201(2):450-5. PubMed ID: 323464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effect of glucose, but not 3-O-methyl glucose, against alloxan-induced diabetes depends upon the route of hexose administration.
    Jansson L; Sandler S
    Arch Int Pharmacodyn Ther; 1988; 293():257-64. PubMed ID: 3048222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention of alloxan-induced diabetes in mice by the iron-chelator detapac: suggestion of a role for iron in the cytotoxic process.
    Heikkila RE; Cabbat FS
    Experientia; 1982 Mar; 38(3):378-9. PubMed ID: 6804257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,10 phenanthroline, a metal chelator, protects against alloxan- but not streptozotocin-induced diabetes.
    Eizirik DL; de Lúcio MA; Boschero AC; Hoffmann ME
    J Free Radic Biol Med; 1986; 2(3):189-92. PubMed ID: 3033047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on biological damage by active oxygen. I. Protective effect of various hydroxyl radical scavengers against alloxan-induced diabetes].
    Sakurai K; Miura T; Ogiso T
    Yakugaku Zasshi; 1986 Nov; 106(11):1034-9. PubMed ID: 3031266
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective effects of gamma-hydroxybutyrate on alloxan induced diabetes in mice.
    Pierrefiche G; Topall G; Henriet I; Laborit H
    Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):309-19. PubMed ID: 2047574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the protective activity of ICRF-187 against alloxan-induced diabetes in mice.
    el-Hage A; Herman EH; Yang GC; Crouch RK; Ferrans VJ
    Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):341-60. PubMed ID: 3090662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice.
    Ho E; Chen G; Bray TM
    FASEB J; 1999 Oct; 13(13):1845-54. PubMed ID: 10506589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against alloxan-induced diabetes by various dialkyldithiocarbamates.
    Masukawa T; Nakanishi K; Katakawa J; Tetsumi T
    Experientia; 1995 Jan; 51(1):29-31. PubMed ID: 7843327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protective effect of verapamil against alloxan-induced damage on pancreatic islet beta-cells in rats].
    Wei YJ; Yu GZ; Zhang GF; Yu JR
    Sheng Li Xue Bao; 1992 Apr; 44(2):209-14. PubMed ID: 1621112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of alloxan toxicity on the beta cell.
    Rossini AA; Arcangeli MA; Cahill GF
    Diabetes; 1975 May; 24(5):516-22. PubMed ID: 1092583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.